Abstract:These surveys of organ procurement organizations and transplant professionals demonstrate variability in donor testing, donor antimicrobial utilization, and transplant provider opinions regarding the need for and selection of antimicrobial agents. Findings highlight opportunities for standardized approaches to donor testing and management. Background Donor screening and antimicrobial management processes are inconsistent across organ procurement organizations (OPOs) and transplant centers. As part of a Controversies Conference addressing the evaluation and management of infectious diseases (ID) in deceased donors sponsored by the American Society of Transplantation (AST), two online pre‐meeting surveys were developed to inform conference proceedings and assess current practices and opinions on donor screening and antimicrobial management. Methods Survey 1 addressed the current state of deceased donor ID testing, culture data communication, antimicrobial utilization, and involvement of transplant ID during donor management and was distributed to all 56 United States OPOs. Survey 2 evaluated transplant professionals' opinions regarding donor antimicrobial use and was sent to the AST Infectious Disease, Kidney Pancreas, Liver and Intestinal, and Thoracic and Critical Care Community of Practice listservs. Descriptive statistics were performed. Results Thirty‐five (63%) unique responses were received from OPOs for Survey 1. Findings included variability in the timing of donor culture collection, frequent sampling of indwelling catheters, wide variation in the location of culture processing, and availability of additional susceptibility testing. Eighty‐eight unique responses were received from approximately 1552 (6%) transplant providers for Survey 2. Of the respondents, 37% would not recommend standard antibiotics prior to organ recovery in the absence of suspected or confirmed infection. Conclusions These surveys demonstrate variability in donor testing, donor antimicrobial utilization, and transplant provider opinions regarding the need for and selection of antimicrobial agents. Findings highlight opportunities for standardized approaches to donor testing and management.

Perspective on donor‐derived infections in Italy

Perspectives on donor‐derived infections from the Notify Library

Perspectives on donor-derived infections from Germany

Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management

Clinical approach to donor‐derived infection in solid organ transplant recipients

Inequities in Organ Donation and Transplantation Among Immigrant Populations in Italy: A Narrative Review of Evidence, Gaps in Research and Potential Areas for Intervention

Global perspectives on donor‐derived infections: Brazil and Argentina

Donor‐derived infections: The Swiss perspective

Incidence, Distribution and Clinical Relevance of Microbial Contamination of Preservation Solution in Deceased Kidney Transplant Recipients: a Retrospective Cohort Study from China.

Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety

Impact of donor multidrug‐resistant organisms on solid organ transplant recipient outcomes

Donor‐derived infections in the United States: Opportunities to learn from the Disease Transmission Advisory Committee's experience

Minding the gap: How transplant infectious disease can help close the organ donation gap

Deceased Donor Infectious Diseases Testing and Antimicrobial Use: Surveys of Organ Procurement Organizations and Transplant Professionals

Risk Assessment and Management for Potential Living Kidney Donors: The Role of "Third-Party" Commission

Recent advances in cytomegalovirus infection management in solid organ transplant recipients

Recent advances in understanding and managing infectious diseases in solid organ transplant recipients

Monocentric, Retrospective Study on Infectious Complications within One Year after Solid-Organ Transplantation at a Belgian University Hospital

Surveillance for donor‐derived infections in Australia

Donor‐derived mold infections in lung transplant recipients: The importance of active surveillance

A Digital Approach to Improve Infection Screening Among Solid Organ Transplant Candidates